{"disease":{"id":"exclusive-enteral-nutrition","name":"exclusive enteral nutrition"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04999241","title":"Combined Application of EEN in the Induction of Remission in PUC","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT04530877","title":"Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}